These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7041943)

  • 1. A trial of nonspecific immunotherapy using systemic C. parvum in treated patients with Dukes B and C colorectal cancer.
    Souter RG; Gill PG; Morris PJ
    Br J Cancer; 1982 Apr; 45(4):506-12. PubMed ID: 7041943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure.
    Wunderlich M; Schiessel R; Rainer H; Rauhs R; Kovats E; Schemper M; Dittrich C; Micksche M; Sedlacek HH
    Br J Surg; 1985 Sep; 72 Suppl():S107-10. PubMed ID: 3899250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative nonspecific immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer. A prospective randomized study].
    Grundmann R; Weber F; Kluger J; Wienand P; Pulverer G
    Chirurg; 1988 Apr; 59(4):272-8. PubMed ID: 3289850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.
    Hoover HC; Surdyke MG; Dangel RB; Peters LC; Hanna MG
    Cancer; 1985 Mar; 55(6):1236-43. PubMed ID: 3882219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial of 5-fluorouracil and Corynebacterium parvum in advanced colorectal carcinoma.
    Gough IR; Clunie GJ; Bolton PM; Dury M; Burnett W
    Dis Colon Rectum; 1979; 22(4):223-7. PubMed ID: 313873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Corynebacterium parvum on human effector cells in peripheral blood.
    Gill PG; Waller CA; Clarke J; Darley J; Morris PJ
    Dev Biol Stand; 1977 Apr 13-15; 38():455-60. PubMed ID: 608538
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER).
    Robinson E; Bartal A; Cohen Y; Milstein D; Mekori T
    Biomedicine; 1979 Feb; 31(1):8-10. PubMed ID: 383171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experiences with a nation-wide Austrian study of adjuvant chemo- and immunotherapy of colorectal cancer following radical surgery].
    Karrer K; Denck H; Pridun N
    Acta Med Austriaca Suppl; 1979; 6():325-6. PubMed ID: 299221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma.
    Gough IR; Bolton PM; Clunie GJ; Burnett W
    Aust N Z J Surg; 1978 Jun; 48(3):296-300. PubMed ID: 281221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melbourne trial of adjuvant immunotherapy in operable large bowel cancer.
    Gray BN; Walker C; Andrewartha L; Freeman S; Bennett RC
    Aust N Z J Surg; 1988 Jan; 58(1):43-6. PubMed ID: 3046593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.
    Bancewicz J; Calman KC; Macpherson SG; McArdle CS; McVie JG; Soukop M
    J R Soc Med; 1980 Mar; 73(3):197-9. PubMed ID: 7014886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for resectable rectal and colonic cancer.
    Heriot AG; Kumar D
    Br J Surg; 1998 Mar; 85(3):300-9. PubMed ID: 9529480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy of colorectal cancer. Why we still don't know.
    Buyse M; Zeleniuch-Jacquotte A; Chalmers TC
    JAMA; 1988 Jun; 259(24):3571-8. PubMed ID: 3286920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of colorectal cancer.
    Påhlman L
    Ann Chir Gynaecol; 2000; 89(3):216-20. PubMed ID: 11079791
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of specific active immunotherapy in lung cancer.
    Souter RG; Gill PG; Gunning AJ; Morris PJ
    Br J Cancer; 1981 Oct; 44(4):496-501. PubMed ID: 7028069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Colorectal cancer. A study of 133 surgical cases].
    Arthur KE; Perurena J
    Rev Med Panama; 1993 Jan; 18(1):1-15. PubMed ID: 8475334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood transfusion effect and colorectal cancer recurrence.
    Parrott NR; Taylor RM; Lennard TW; Shenton BK; Proud G; Johnston ID
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1475. PubMed ID: 3274360
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
    Larsen SG; Wiig JN; Giercksky KE
    Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of environment and healthcare structures on the survival of patients with colorectal cancer: a French population-based study.
    Borie F; Daurès JP; Millat B; Puch P; Tretarre B
    J Surg Oncol; 2002 Jul; 80(3):137-42. PubMed ID: 12115796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
    Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
    Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.